Rainier Group Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$564K Buy
3,789
+1,008
+36% +$149K 0.22% 28
2020
Q2
$391K Buy
+2,781
New +$405K 0.17% 29
2020
Q1
Sell
-2,209
Closed -$322K 30
2019
Q4
$322K Sell
2,209
-264
-11% -$35.8K 0.13% 33
2019
Q3
$320K Buy
2,473
+192
+8% +$25.3K 0.15% 32
2019
Q2
$318K Buy
2,281
+551
+32% +$76.3K 0.14% 30
2019
Q1
$242K Buy
+1,730
New +$232K 0.11% 36
2018
Q4
Sell
-1,636
Closed -$226K 37
2018
Q3
$226K Buy
+1,636
New +$217K 0.09% 35
2018
Q2
Sell
-4,423
Closed -$567K 40
2018
Q1
$567K Hold
4,423
0.26% 24
2017
Q4
$618K Hold
4,423
0.31% 16
2017
Q3
$575K Sell
4,423
-30
-0.7% -$3.98K 0.31% 17
2017
Q2
$589K Sell
4,453
-85
-2% -$10.8K 0.33% 15
2017
Q1
$565K Sell
4,538
-976
-18% -$117K 0.27% 19
2016
Q4
$635K Buy
+5,514
New +$637K 0.3% 20

Other funds holding JNJ

Rainier Group Investment Advisory's JNJ Position: Q3 2020 in Review

Rainier Group Investment Advisory increased its Johnson & Johnson (JNJ) stake by 36% in Q3 2020, buying an estimated $149K and bringing the position to 3,789 shares worth $564K. The position accounts for 0.22% of the portfolio, ranked #28.

Rainier Group Investment Advisory first reported a position in JNJ in Q4 2016 and has held it in 13 quarters since. The position peaked at $635K in Q4 2016. 2,984 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Rainier Group Investment Advisory held 3,789 shares of Johnson & Johnson worth $564K as of Q3 2020.
  • Rainier Group Investment Advisory bought 1,008 Johnson & Johnson shares in Q3 2020, an estimated $149K.
  • Johnson & Johnson made up 0.22% of Rainier Group Investment Advisory's portfolio in Q3 2020, its #28 holding.
  • Rainier Group Investment Advisory first reported a position in Johnson & Johnson in Q4 2016 and has held it in 13 quarters since.
  • Rainier Group Investment Advisory's Johnson & Johnson position peaked at $635K in Q4 2016.
  • 2,984 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Rainier Group Investment Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.